How to buy Inovalon stock

Inovalon Holdings, Inc is a health information services business based in the US. Inovalon shares (INOV) are listed on the NASDAQ and all prices are listed in US Dollars. Inovalon employs 1,836 staff and has a trailing 12-month revenue of around 0.00.

Inovalon share price

Use our graph to track the performance of INOV stocks over time.

Inovalon shares at a glance

• Key figures

Information last updated 2021-04-29.

52-week range	$15.15 - $30.77
50-day moving average	$28.64
200-day moving average	$24.12
Wall St. target price	$29.38
PE ratio	200.3425
Dividend yield	N/A (0%)
Earnings per share (TTM)	$0.15

Buy Inovalon shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Inovalon stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Inovalon Holdings, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Inovalon under- or over-valued?

Valuing Inovalon stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Inovalon's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Inovalon's P/E ratio

Inovalon's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 200x. In other words, Inovalon shares trade at around 200x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Inovalon's PEG ratio

Inovalon's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 5.24. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Inovalon's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Inovalon's EBITDA

Inovalon's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $189.7 million.

The EBITDA is a measure of a Inovalon's overall financial performance and is widely used to measure a its profitability.

Inovalon financials

Revenue TTM	$667.5 million
Operating margin TTM	11.2%
Gross profit TTM	$499.7 million
Return on assets TTM	2.41%
Return on equity TTM	3.23%
Profit margin	3.38%
Book value	$4.56
Market capitalisation	$4.6 billion

TTM: trailing 12 months

Shorting Inovalon shares

There are currently 3.6 million Inovalon shares held short by investors – that's known as Inovalon's "short interest". This figure is 1.1% down from 3.6 million last month.

There are a few different ways that this level of interest in shorting Inovalon shares can be evaluated.

Inovalon's "short interest ratio" (SIR)

Inovalon's "short interest ratio" (SIR) is the quantity of Inovalon shares currently shorted divided by the average quantity of Inovalon shares traded daily (recently around 467191.59001314). Inovalon's SIR currently stands at 7.61. In other words for every 100,000 Inovalon shares traded daily on the market, roughly 7610 shares are currently held short.

However Inovalon's short interest can also be evaluated against the total number of Inovalon shares, or, against the total number of tradable Inovalon shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Inovalon's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Inovalon shares in existence, roughly 20 shares are currently held short) or 0.0476% of the tradable shares (for every 100,000 tradable Inovalon shares, roughly 48 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Inovalon.

Find out more about how you can short Inovalon stock.

Inovalon share dividends

We're not expecting Inovalon to pay a dividend over the next 12 months.

Inovalon share price volatility

Over the last 12 months, Inovalon's shares have ranged in value from as little as $15.15 up to $30.77. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Inovalon's is 0.5962. This would suggest that Inovalon's shares are less volatile than average (for this exchange).

Inovalon overview

Inovalon Holdings, Inc. provides cloud-based platforms for data-driven healthcare. It operates Inovalon ONE Platform, an integrated, real-time cloud native platform that interconnect with the healthcare ecosystem to aggregate and analyze data in real-time, as well as empowers the application in resulting insights. The company also operates myABILITY software platform, an integrated set of cloud-based applications for providers that offers connectivity, administrative, clinical and quality analysis, management, and performance improvement capabilities to acute, post-acute, and ambulatory point-of-care provider facilities. In addition, it offers advisory, implementation, and support services. The company serves health plans and provider organizations, as well as pharmaceutical, medical device, and diagnostics companies. Its platforms include information of data pertaining to approximately one million physicians; 574,000 clinical facilities; and approximately 332 million individuals and 61 billion medical events.

Frequently asked questions

• What percentage of Inovalon is owned by insiders or institutions?

  Currently 4.275% of Inovalon shares are held by insiders and 69.932% by institutions.

• How many people work for Inovalon?

  Latest data suggests 1,836 work at Inovalon.

• When does the fiscal year end for Inovalon?

  Inovalon's fiscal year ends in December.

• Where is Inovalon based?

  Inovalon's address is: 4321 Collington Road, Bowie, MD, United States, 20716

• What is Inovalon's ISIN number?

  Inovalon's international securities identification number is: US45781D1019

• What is Inovalon's CUSIP number?

  Inovalon's Committee on Uniform Securities Identification Procedures number is: 45781D101